Ayunan, Fatresia .

HRN: 26-98-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
04/15/2025
04/18/2025
ORAL
5 Ml
BID
T/c Ascariasis
Waiting Final Action 
04/16/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/16/2025
04/22/2025
0RAL
11ml
TID
AGE
Waiting Final Action 
04/17/2025
CEFTRIAXONE 1G (VIAL)
04/17/2025
04/24/2025
IV
1gm
Q12
Typhoid Fever; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: